Literature DB >> 27097372

microRNA-496 - A new, potentially aging-relevant regulator of mTOR.

Claudia Rubie1, Kathrin Kölsch1, Beata Halajda1, Hermann Eichler2, Stefan Wagenpfeil3, Klaus Roemer4, Matthias Glanemann1.   

Abstract

Recent findings strongly support a role for small regulatory RNAs in the regulation of human lifespan yet little information exists about the precise underlying mechanisms. Although extensive studies on model organisms have indicated that reduced activity of the nutrient response pathway, for example as a result of dietary restriction, can extend lifespan through the suppression of the protein kinase mechanistic target of rapamycin (mTOR), it still is subject of debate whether this mechanism is operative in humans as well. Here, we present findings indicating that human microRNA (miR)-496 targets 2 sites within the human mTOR 3'UTR. Coexpression of miR-496 with different fusion transcripts, consisting of the luciferase transcript and either wild-type mTOR 3'UTR or mTOR 3'UTR transcript with the miR-496 binding sites singly or combined mutated, confirmed this prediction and revealed cooperativity between the 2 binding sites. miR-496 reduced the mTOR protein level in HeLa-K cells, and the levels of miR-496 and mTOR protein were inversely correlated in Peripheral Blood Mononuclear Cells (PBMC), with old individuals (n = 40) harbouring high levels of miR-496 relative to young individuals (n = 40). Together, these findings point to the possibility that miR-496 is involved in the regulation of human aging through the control of mTOR.

Entities:  

Keywords:  Human aging; PBMC; gene regulation; mTOR; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27097372      PMCID: PMC4889276          DOI: 10.1080/15384101.2016.1158360

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

1.  miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells.

Authors:  Benjamin Vicinus; Claudia Rubie; Sabrina K Faust; Vilma Oliveira Frick; Pirus Ghadjar; Mathias Wagner; Stefan Graeber; Martin K Schilling
Journal:  Cancer Lett       Date:  2011-10-29       Impact factor: 8.679

Review 2.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 3.  microRNA: a master regulator of cellular processes for bioengineering systems.

Authors:  Wei Sun; Yi-Shuan Julie Li; Hsien-Da Huang; John Y-J Shyy; Shu Chien
Journal:  Annu Rev Biomed Eng       Date:  2010-08-15       Impact factor: 9.590

4.  Improved method for simultaneous isolation of proteins and nucleic acids.

Authors:  Soroth Chey; Claudia Claus; Uwe Gerd Liebert
Journal:  Anal Biochem       Date:  2010-11-19       Impact factor: 3.365

5.  Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.

Authors:  Matt Kaeberlein; R Wilson Powers; Kristan K Steffen; Eric A Westman; Di Hu; Nick Dang; Emily O Kerr; Kathryn T Kirkland; Stanley Fields; Brian K Kennedy
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

Review 6.  Growth and aging: a common molecular mechanism.

Authors:  Mikhail V Blagosklonny; Michael N Hall
Journal:  Aging (Albany NY)       Date:  2009-04-20       Impact factor: 5.682

7.  Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression.

Authors:  J Kunz; R Henriquez; U Schneider; M Deuter-Reinhard; N R Movva; M N Hall
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

8.  Rapamycin slows aging in mice.

Authors:  John E Wilkinson; Lisa Burmeister; Susan V Brooks; Chi-Chao Chan; Sabrina Friedline; David E Harrison; James F Hejtmancik; Nancy Nadon; Randy Strong; Lauren K Wood; Maria A Woodward; Richard A Miller
Journal:  Aging Cell       Date:  2012-06-04       Impact factor: 9.304

9.  Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells.

Authors:  Claudia Rubie; Bianca Kruse; Vilma Oliveira Frick; Kathrin Kölsch; Pirus Ghadjar; Mathias Wagner; Friedrich Grässer; Stefan Wagenpfeil; Mathias Glanemann
Journal:  J Transl Med       Date:  2014-02-21       Impact factor: 5.531

10.  miRecords: an integrated resource for microRNA-target interactions.

Authors:  Feifei Xiao; Zhixiang Zuo; Guoshuai Cai; Shuli Kang; Xiaolian Gao; Tongbin Li
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

View more
  8 in total

Review 1.  Evaluating the beneficial effects of dietary restrictions: A framework for precision nutrigeroscience.

Authors:  Kenneth A Wilson; Manish Chamoli; Tyler A Hilsabeck; Manish Pandey; Sakshi Bansal; Geetanjali Chawla; Pankaj Kapahi
Journal:  Cell Metab       Date:  2021-09-22       Impact factor: 31.373

2.  MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF in osteosarcoma.

Authors:  Jing Ye; Wei Xie; Yunzhou Zuo; Guangwu Jing; Jie Tong
Journal:  Exp Ther Med       Date:  2019-12-19       Impact factor: 2.447

Review 3.  Regulation of mTOR signaling by long non-coding RNA.

Authors:  Karam Aboudehen
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-11-18       Impact factor: 4.490

Review 4.  MicroRNAs and the metabolic hallmarks of aging.

Authors:  Berta Victoria; Yury O Nunez Lopez; Michal M Masternak
Journal:  Mol Cell Endocrinol       Date:  2017-01-03       Impact factor: 4.102

5.  LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.

Authors:  Qing-Chun Lu; Zhuang-Hua Rui; Zhong-Liang Guo; Wang Xie; Shan Shan; Tao Ren
Journal:  J Cell Mol Med       Date:  2017-12-20       Impact factor: 5.310

6.  Nectandrin B-mediated activation of the AMPK pathway prevents cellular senescence in human diploid fibroblasts by reducing intracellular ROS levels.

Authors:  Hyun-Jin Jang; Kyeong Eun Yang; Won Keun Oh; Song-I Lee; In-Hu Hwang; Kyung-Tae Ban; Hwa-Seung Yoo; Jong-Soon Choi; Eui-Ju Yeo; Ik-Soon Jang
Journal:  Aging (Albany NY)       Date:  2019-06-14       Impact factor: 5.682

7.  A systematic integrative approach reveals novel microRNAs in diabetic nephropathy.

Authors:  Farnoush Kiyanpour; Maryam Abedi; Yousof Gheisari
Journal:  J Res Med Sci       Date:  2020-01-20       Impact factor: 1.852

8.  MicroRNA-496 inhibits triple negative breast cancer cell proliferation by targeting Del-1.

Authors:  Soo Jung Lee; Jae-Hwan Jeong; Jeeyeon Lee; Ho Yong Park; Jin Hyang Jung; Jieun Kang; Eun Ae Kim; Nora Jee-Young Park; Ji-Young Park; In Hee Lee; Yee Soo Chae
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.